Visual Dysfunction in Diabetes

Lieferzeit: Lieferbar innerhalb 14 Tagen

160,49 

The Science of Patient Impairment and Health Care, Incl DVD, Ophthalmology Research

ISBN: 160761149X
ISBN 13: 9781607611493
Herausgeber: Joyce Tombran-Tink/Colin J Barnstable/Thomas W Gardner
Verlag: Humana Press
Umfang: xv, 379 S.
Erscheinungsdatum: 15.12.2011
Auflage: 1/2012
Produktform: Buch
Einband: GEB

Details the role of neuronal, glial, and inflammatory components in early stages of diabetic retinopathyProposes new perspective on diabetic retinopathy, maintaining it is the result of an interacting spectrum of changes affecting many different cell typesPresents a new approach to following diabetic retinopathy through its various stages of progressionCovers recent genetics and molecular mechanisms identified with the progression of the diseaseExplores the risk factors and complications and innovative screening methods, such as the use of ERGs, to diagnose the earliest stages of diabetic retinopathyIncludes supplementary material: sn.pub/extras

Artikelnummer: 1493225 Kategorie:

Beschreibung

InhaltsangabeIntroductionDiabetic Retinopathy - what we know, don't know, and need to know - Tom GardnerLiving with Diabetic Retinopathy Ch. 1 A Patient's viewpoint: Heather StuckeyCh. 2 What patients with diabetes see-and don't see: subjective and objective visual functionchanges - Shelly BoydCh. 3 How do I know I have diabetic retinopathy - a clinician's view? - David QuillenPrevalence, Public Awareness, and Screening Methods Ch. 4 Epidemiology & Economics - John Javitt Ch. 5 Correlation between the presence and severity of diabetic retinopathy in families with diabetes- Victor Gonzalez Ch. 6 Increasing public awareness of the diabetes endemic - Ian ConstableCh. 7 Nutrition and diabetes- David NathanCh. 8 Diabetic retinopathy screening - progress and complications - Peter Scanlon Diagnosing Diabetic Retinopathy Ch. 9 Measurements of retinal blood flow, vascular leakage, and oxygenation - Einer StefanssonCh. 10 Optical imaging - Confocal microscopy to detect retinal vasculature - Martin FriedlanderCh. 11 Structural imaging - OCT - M. LarsenCh. 12 Functional imaging - ERG - Anthony Adams How Diabetes Affects the EyeCh. 13 Clinical phenotypes (reclassification) - J. Cunha-VazCh. 14 Vascular changes - David Antonetti & Tom Gardiner (Belfast)Ch. 15 Neuronal changes - Alistair Barber/Greg JacksonCh. 16 Inflammatory changes - Mark TsoCh. 17 Other Ocular Complications of Diabetes - Shoja MR New Approaches to Diabetic RetinopathyCh. 18 New insights in the pathogenesis of diabetic retinopathy using a proteomic approach - Retina -Quin GGCh. 19 Vitreous proteomics - Ed FeenerCh. 20 Genomics - Bill FreemanCh. 21 Genome-wide linkage analyses to identify Loci for diabetic retinopathy - Kang Zhang (Utah)Risk Factors Ch. 22 Diabetic retinopathy correlates with increased incidence of cardiovascular events -Cheung NCh. 23 Pregnancy and rate of progression of diabetic retinopathy - Sheth BP Molecular Mechanisms that Could Trigger Visual Dysfunction in DiabetesIntroduction - Tom GardnerCh. 24 Inflammation in the early pathogenesis of diabetic retinopathy -beauty and beast. - Chris Norbury (Hershey)Ch. 25 Oxidative stress and diabetic retinopathy. - Catherine WhitesideCh. 26 Glucose induced cellular signaling in diabetic retinopathy - Chakrabarti SCh. 27 The AGE/RAGE axis in early diabetic retinopathy - Schmidt AMCh. 28 Proteases and the retinal vasculature (and maybe the whole retina!) - Arup Das.Ch. 29 IGFBP3 and retinal vessel growth. Smith LECh. 30 PEDF, VEGF, CTGF review - JX MaCh. 31 A decrease in the expression of somatostatin is an early event in diabetic retinopathy -Carrasco ECh. 32 Connective tissue and connective tissue growth factor in diabetic retinopathy - SchlingemannROCh. 33 Molecular regulation of endothelial cell tight junctions and the blood retinal barrier - AntonettiDACh. 34 Pericytes and diabetic retinopathy - Puro DGCh. 35 Leukostasis - Adamis, APCh. 36 Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes. -Khalfaoui T, Ch. 37 Azurocidin as a Permeability Factor in the Retina - Hafezi-Moghadam ACh. 38 Retinal arteriolar hemodynamic response to a combined isocapnic hyperoxia and glucoseprovocation in early sight-threatening diabetic retinopathy. - Devenyi RG.Ch. 39 Urinary 8-hydroxydeoxyguanosine (8-OHdG) levels in diabetic retinopathy patients. - SteveAbcouwerCh. 40 Tyrosine nitration in the molecular mechanisms of diabetic retinopathy. - Crabb J

Autorenporträt

InhaltsangabeIntroductionDiabetic Retinopathy - what we know, don't know, and need to know - Tom GardnerLiving with Diabetic Retinopathy Ch. 1 A Patient's viewpoint: Heather StuckeyCh. 2 What patients with diabetes see-and don't see: subjective and objective visual functionchanges - Shelly BoydCh. 3 How do I know I have diabetic retinopathy - a clinician's view? - David QuillenPrevalence, Public Awareness, and Screening Methods Ch. 4 Epidemiology & Economics - John Javitt Ch. 5 Correlation between the presence and severity of diabetic retinopathy in families with diabetes- Victor Gonzalez Ch. 6 Increasing public awareness of the diabetes endemic - Ian ConstableCh. 7 Nutrition and diabetes- David NathanCh. 8 Diabetic retinopathy screening - progress and complications - Peter Scanlon Diagnosing Diabetic Retinopathy Ch. 9 Measurements of retinal blood flow, vascular leakage, and oxygenation - Einer StefanssonCh. 10 Optical imaging - Confocal microscopy to detect retinal vasculature - Martin FriedlanderCh. 11 Structural imaging - OCT - M. LarsenCh. 12 Functional imaging - ERG - Anthony Adams How Diabetes Affects the EyeCh. 13 Clinical phenotypes (reclassification) - J. Cunha-VazCh. 14 Vascular changes - David Antonetti & Tom Gardiner (Belfast)Ch. 15 Neuronal changes - Alistair Barber/Greg JacksonCh. 16 Inflammatory changes - Mark TsoCh. 17 Other Ocular Complications of Diabetes - Shoja MR New Approaches to Diabetic RetinopathyCh. 18 New insights in the pathogenesis of diabetic retinopathy using a proteomic approach - Retina -Quin GGCh. 19 Vitreous proteomics - Ed FeenerCh. 20 Genomics - Bill FreemanCh. 21 Genome-wide linkage analyses to identify Loci for diabetic retinopathy - Kang Zhang (Utah)Risk Factors Ch. 22 Diabetic retinopathy correlates with increased incidence of cardiovascular events -Cheung NCh. 23 Pregnancy and rate of progression of diabetic retinopathy - Sheth BP Molecular Mechanisms that Could Trigger Visual Dysfunction in DiabetesIntroduction - Tom GardnerCh. 24 Inflammation in the early pathogenesis of diabetic retinopathy -beauty and beast. - Chris Norbury (Hershey)Ch. 25 Oxidative stress and diabetic retinopathy. - Catherine WhitesideCh. 26 Glucose induced cellular signaling in diabetic retinopathy - Chakrabarti SCh. 27 The AGE/RAGE axis in early diabetic retinopathy - Schmidt AMCh. 28 Proteases and the retinal vasculature (and maybe the whole retina!) - Arup Das.Ch. 29 IGFBP3 and retinal vessel growth. Smith LECh. 30 PEDF, VEGF, CTGF review - JX MaCh. 31 A decrease in the expression of somatostatin is an early event in diabetic retinopathy -Carrasco ECh. 32 Connective tissue and connective tissue growth factor in diabetic retinopathy - SchlingemannROCh. 33 Molecular regulation of endothelial cell tight junctions and the blood retinal barrier - AntonettiDACh. 34 Pericytes and diabetic retinopathy - Puro DGCh. 35 Leukostasis - Adamis, APCh. 36 Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes. -Khalfaoui T, Ch. 37 Azurocidin as a Permeability Factor in the Retina - Hafezi-Moghadam ACh. 38 Retinal arteriolar hemodynamic response to a combined isocapnic hyperoxia and glucoseprovocation in early sight-threatening diabetic retinopathy. - Devenyi RG.Ch. 39 Urinary 8-hydroxydeoxyguanosine (8-OHdG) levels in diabetic retinopathy patients. - SteveAbcouwerCh. 40 Tyrosine nitration in the molecular mechanisms of diabetic retinopathy. - Crabb J

Das könnte Ihnen auch gefallen …